Nivolumab vs. Chemo in Relapsed SCLC (review of Checkmate-331 trial)

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Nivolumab vs. Chemo in Relapsed SCLC (review of Checkmate-331 trial)

By Beacon Medical Interchange FEATURING Jack West

181 views

December 27, 2018

Dr. Jack West reviews the trial design, key results, and implications of the CheckMate-331 trial ...
read more ↘ of nivolumab (Opdivo) vs. standard chemotherapy for relapsed small cell lung cancer.
↖ read less

0 Comments

Recent Updates in SCLC

Feat. S. Kazmi